Cornea/External Disease News

Improvements in multiple sign efficacy endpoints were reported for licaminlimab in patients with dry eye disease, with more pronounced effects in patients with a TNFR1 genetic biomarker, according to an Oculis press release.

The neutrophil-to-lymphocyte ratio appeared to distinguish between acute orbital infectious disease and noninfectious inflammation and may aid in clinical intervention, according to a study in Ophthalmic Plastic and Reconstructive Surgery.

Catch up on the top five items in dry eye disease from May.

Some individual meibomian gland metrics may structurally change over a period of hours or days, according to research published in Ophthalmic and Physiological Optics.

Bausch + Lomb has launched Blink NutriTears, an over-the-counter supplement designed to target the root causes of dry eye disease and promote healthy tear production, the company announced in a press release.

Azura Ophthalmics announced that the first patient has been enrolled in the phase 3 ASTRO study of AZR-MD-001 for patients with clinical signs and symptoms of meibomian gland dysfunction.

Vevye, a nonpreserved cyclosporine 0.1% ophthalmic solution, demonstrated sustained safety and efficacy among patients with dry eye disease, according to 52-week ESSENCE-2 open-label extension study results published in Cornea.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Roger Kennedy, director of marketing for BioTissue, announces the launch of the CAM360 AmnioGraft.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Eric D. Donnenfeld, MD, discusses Lacrifill for the management of dry eye disease.

Catch up on the top Healio Video Perspectives from this year’s Association for Research in Vision and Ophthalmology meeting.